Concepedia

Brenda Hsu

BH

Statistics

Publications

5

Citations

233

H-Index

5

Active since

1993

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Brenda Hsu is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, cell death, and tumor biology.

Top concepts

MedicineApoptosisPathologyCell DeathImmunologyCell BiologyTumor BiologyCancer ResearchHealthAutoimmunity

Publications per year

1993–1995

5

Publications

5

Evidence that c-myc mediated apoptosis does not require wild-type p53 during lymphomagenesis.

Brenda Hsu, María C. Marín, A. K. El-Naggar et al. · PubMed · 1995 · 83 citations

The Functional Basis of c-myc and bcl-2 Complementation during Multistep Lymphomagenesis in Vivo

María C. Marín, Brenda Hsu, L. Clifton Stephens et al. · Experimental Cell Research · 1995 · 73 citations

Hematological Malignancy, Lymphoid Neoplasia, Functional Basis +11

The bcl-2 Oncogene: Apoptosis and Neoplasia

Timothy J. McDonnell, María C. Marín, Brenda Hsu et al. · Radiation Research · 1993 · 50 citations

Hematological Malignancy, Lymphoid Neoplasia, Bcl-2 Oncogene +14

Expression of bcl-2 gene confers multidrug resistance to chemotherapy- induced cell death

Brenda Hsu, María C. Marín, Shawn Brisbay et al. · The Cancer bulletin of the University of Texas M.D. Anderson Hospital and Tumor Institute at Houston · 1994 · 16 citations

Bcl-2 Gene Confers, Health Sciences, Medicine +9

Cell death regulation during multistep lymphomagenesis

Brenda Hsu, María C. Marín, Timothy J. McDonnell · Cancer Letters · 1995 · 11 citations

Lymphoid Neoplasia, Apoptosis, Cell Death Regulation +6

1–5 of 5